Determination of faecal inflammatory marker concentration as a noninvasive method of evaluation of pathological activity in children with inflammatory bowel diseases

Advances in Medical Sciences

Volumn 60, Issue 2, 2015, Pages 246-252

  Roszak, Dorota ^a   Gałęcka, Mirosława ^b   Cichy, Wojciech ^a   Szachta, Patrycja ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Institute of Microecology   (Poland)

Author keywords

Calprotectin; IBD; Inflammatory markers; Lactoferrin; M2 PK

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALGRANULIN; FIBRINOGEN; HEMOGLOBIN; IRON; LACTOFERRIN; PYRUVATE KINASE;

ADOLESCENT; ALBUMIN BLOOD LEVEL; ARTICLE; CHILD; CHILDHOOD DISEASE; CROHN DISEASE; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FECES; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZED CHILD; HUMAN; INFLAMMATORY BOWEL DISEASE; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT; ULCERATIVE COLITIS; CHEMISTRY; INFLAMMATION; METABOLISM; PRESCHOOL CHILD;

ADOLESCENT; BIOMARKERS; CHILD; CHILD, PRESCHOOL; FECES; FEMALE; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; LACTOFERRIN; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; PYRUVATE KINASE;

EID: 84940989717     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.1016/j.advms.2015.04.003     Document Type: Article

References (27)

1. G.L. Austin, H.H. Herfarth, and R.S. Sandler A critical evaluation of serologic markers for inflammatory bowel disease Clin Gastroenterol Hepatol 5 2007 545 547
2. A. Pera, P. Bellando, D. Caldera, V. Ponti, M. Astegiano, C. Barletti, and et al. Colonoscopy in inflamatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score Gastroenterology 92 1987 181 185
3. M.B. de Mesquita, F. Civitelli, and A. Levine Epidemiology, genes and inflammatory bowel diseases in childhood Dig Liver Dis 4 2008 3 11
4. E.E.S. Nieuwenhuis, and J.C. Escher Early onset IBD: what's the difference? Dig Liver Dis 40 1 2008 12 15
5. J. Däbritz, J. Musci, and D. Foell Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome World J Gastroenterol 20 2 2014 363 375
6. E. Burri, and C. Beglinger IBD. Faecal calprotectin testing - the need for better standardization Nat Rev Gastroenterol Hepatol 2014 10.1038/nrgastro.2014.154
7. N.A. Kennedy, A. Clark, A. Walkden, J.C. Chang, F. Fascí-Spurio, M. Muscat, and et al. Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16-50 years J Crohns Colitis 9 January (1) 2015 41 49 10.1016/j.crohns.2014.07.005
8. E. Stragier, and G. Van Assche The use of fecal calprotectin and lactoferrin in patients with IBD. Review Acta Gastroenterol Belg 76 3 2013 322 328
9. B.P. Abraham, and S. Kane Fecal markers: calprotectin and lactoferrin Gastroenterol Clin North Am 41 2 2012 483 495
10. I. Sudo, M. Igawa, K. Tsuchiya, M. Miyaoka, and T. Saito A study to determine fecal lactoferrin in patients with ulcerative colitis Jpn J Gastroenterol 90 4 1993 824 [in Japanese]
11. T.R. Walker, M.L. Land, A. Kartashov, T.M. Saslowsky, D.M. Lyerly, J.H. Boone, and et al. Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease J Ped Gastroenterol Nutr 44 2007 414 422
12. A. Borkowska Laktoferyna w kale jako wykładnik aktywnos̈ci procesu zapalnego w nieswoistych zapaleniach jelit u dzieci Doctor's thesis 2008 Akademia Medyczna w Gdańsku Gdańsk [in Polish]
13. O. Schröder, M. Naumann, Y. Shastri, N. Povse, and J. Stein Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin Aliment Pharmacol Ther 26 2007 1035 1042
14. T. Aomatsu, A. Yoden, K. Matsumoto, E. Kimura, K. Inoue, A. Andoh, and et al. Fecal calprotectin is a useful marker for disease activity in pediatric patients with inflammatory bowel disease Dig Dis Sci 56 8 2011 2372 2377 10.1007/s10620-011-1633-y
15. E. Olafsdottir, L. Aksnes, G. Fluge, and A. Berstad Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children Acta Peadiatr 91 2002 45 50
16. N. Kobelska-Dubiel, I. Ignys̈, W. Cichy, and M. Kobielski Kliniczne wskaźniki w nieswoistych zapaleniach jelit u dzieci Pediatr Współ, Hepatol Żyw Dz 9 3 2007 167 171 [in Polish]
17. P.F. Van Rheenen, E. Van De Vijver, and V. Fidler Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis BMJ 341 7765 2010 188 10.1136/bmj.c3369
18. A. Bremner, S. Roked, R. Robinson, I. Phillips, and M. Beattie Faecal calprotectin in children with chronic gastrointestinal symptoms Acta Paediatr 94 12 2005 1855 1858
19. C.W. Kim, J.I. Kim, and S.H. Park Usefulness of plasma tumor M2-pyruvate kinase in the diagnosis of gastrointestinal cancer Kor J Gastroenterol 42 2003 387 393
20. U. Haug, D. Rothenbacher, M.N. Wente, C.M. Seiler, C. Stegmaier, and H. Brenner Tumour M2-PK as a stool marker for colorectal cancer: Comparative analysis in a large sample of unselected older adults vs colorectal cancer patients Br J Cancer. 96 9 2007 1329 1334 10.1038/sj.bjc.6603712
21. Y. Kumar, N. Tapuria, N. Kirmani, and B.R. Davidson Tumour M2-pyruvate kinase: a gastrointestinal cancer marker Eur J Gastroenterol Hepatol 19 3 2007 265 276
22. P.D. Hardt, S. Mazurek, and M. Toepler Faecal tumor M2 pyruvate kinase: a new sensitive screening tool for colorectal cancer Br J Cancer 91 2004 980 984
23. E. Czub, K.H. Herzig, A. Szaflarska-Popawska, K. Kiehne, P. Socha, H. Wos̈, and et al. Fecal pyruvate kinase: a potential new marker for intestinal inflammation in children with inflammatory bowel disease Scand J Gastroenterol 42 10 2007 1147 1150
24. G. Chung-Faye, B.H. Hayee, S. Maestranzi, N. Donaldson, I. Forgacs, and R. Sherwood Fecal M2-pyruvate kinase (M2-PK): a novel marker of intestinal inflammation Inflamm Bowel Dis 13 11 2007 1374 1378
25. J. Jeffery, S.J. Lewis, and R.M. Ayling Fecal dimeric M2-pyruvate kinase (tumor M2-PK) in the differential diagnosis of functional and organic bowel disorders Inflamm Bowel Dis 15 2009 1630 1634
26. E. Czub, J.K. Nowak, A. Szaflarska-Poplawska, U. Grzybowska-Chlebowczyk, P. Landowski, J. Moczko, and et al. Comparison of fecal pyruvate kinase isoform M2 and calprotectin in assessment of pediatric inflammatory bowel disease severity and activity Acta Biochem Pol 61 1 2014 99 102
27. S.V. Kane, W.J. Sandborn, P.A. Rufo, A. Zholudev, J. Boone, D. Lyerly, and et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation Am J Gastroenterol 98 6 2003 1310 1314 10.1111/j.1572-0241.2003.07458.x